Rights and permissions
About this article
Cite this article
Interferon-α-2b + ribavirin for hepatitis C worth it. Pharmacoecon. Outcomes News 287, 7 (2000). https://doi.org/10.1007/BF03275634
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275634